Leonard S. Jacob, Director at ANTARES PHARMA, INC. (ATRS), sold 11,400 shares at $5.05 ($58K) on 2014-01-15, disclosed to the SEC on 2014-01-17.
Scheduled sale ($58k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRS | SELL | 2019-04-10 | $276K | — | Filing → |
| ATRS | SELL | 2017-10-11 | $932K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $184K | — | Filing → |